Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Turkey's pharmaceutical industry is undergoing a monumental shift from traditional chemical-based drugs to advanced biological products. As a strategic bridge between Europe and Asia, Turkey has become a significant hub for Monoclonal Antibodies (mAbs) suppliers and manufacturers. The Turkish government’s "Vision 2023" initiative has paved the way for massive investments in biotechnology, specifically targeting oncology, immunology, and rare diseases.
For factories and suppliers looking to penetrate the Turkish market, understanding the local regulatory environment managed by the Turkish Medicines and Medical Devices Agency (TITCK) is crucial. Our monoclonal antibodies and recombinant protein technologies are designed to meet these stringent international standards, ensuring seamless integration into Turkey's healthcare infrastructure.
Monoclonal Antibodies Application in Turkey: From the hospitals in Istanbul to research labs in Ankara, the demand for high-purity mAbs is surging. These biological components are essential for:
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
In the context of Turkey's growing biotech manufacturing, our use of Single-Use Bioreactors is a game changer. Traditional stainless steel facilities are being replaced by flexible, single-use systems that allow Turkish suppliers to switch between different antibody lines rapidly. This "plug-and-play" manufacturing model reduces cross-contamination risks and significantly lowers capital expenditure for local startups in the Technoparks of Istanbul and Izmir.
Turkey is investing heavily in genomic research. mAbs are the cornerstone of personalized therapy, allowing for treatments tailored to the genetic profile of the Turkish population.
There is a strong push for "Localize Turkey," encouraging factories to synthesize APIs and biological intermediates domestically rather than importing 100% of finished products.
AI-driven drug discovery is emerging in Ankara's research institutes, where machine learning helps design more effective monoclonal antibodies for rare diseases.
Drugs and intermediates are widely used in the following aspects (partial):
Whether it is the Turkish pharmaceutical sector or the Middle Eastern chemical market, our products serve as the backbone for advanced therapeutic and diagnostic production. We provide not just the raw materials, but the technical expertise required to implement these biological solutions effectively.
As the demand for Monoclonal Antibodies in Turkey continues to skyrocket, choosing a supplier that understands both the technology and the local market is paramount. Hangzhou Jeci Biochem Technology Co., Ltd. combines international manufacturing excellence with deep localized knowledge. We don't just supply products; we provide biological solutions that power the next generation of medical treatments in Turkey.
Our Turkey-based pharmaceutical clients benefit from our integrated R&D, custom manufacturing capabilities, and our proven track record in the Chinese and International markets. Whether you are developing a new biosimilar, setting up a diagnostic lab, or requiring high-purity pharmaceutical intermediates, our team is ready to support your growth in the Turkish healthcare landscape.
SJ medical
